Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Huang, Bo  [Clear All Filters]
2023
Yang Y, Zhong F, Jiang J, Li M, Yao F, Liu J, Cheng Y, Xu S, Chen S, Zhang H, et al. Bioinformatic analysis of the expression profile and identification of RhoGDI2 as a biomarker in imatinib-resistant K562 cells. Hematology. 2023;28(1):2244856.
Li Y, Zhang K, Ai X, Zhang Q, Jiang L, Long J, Xu H, Feng C, Zhang Y, Tang G, et al. A Biomimetic Peptide Functions as Specific Extracellular Matrix for Quiescence of Stem Cells against Intervertebral Disc Degeneration. Small. 2023:e2300578.
Lv J, Zhou Y, Zhou N, Wang Z, Chen J, Chen H, Wang D, Zhou L, Wei K, Zhang H, et al. Epigenetic modification of locus dictates immune recognition of nascent tumorigenic cells. Sci Transl Med. 2023;15(681):eabq6024.
He Y, Li X, Huang B, Yang Y, Luo N, Song W, Huang B. Exosomal circVMA21 derived from adipose-derived stem cells alleviates sepsis-induced acute kidney injury by targeting miR-16-5p. Shock. 2023.
Zhong F-M, Yao F-Y, Yang Y-L, Liu J, Li M-Y, Jiang J-Y, Zhang N, Xu Y-M, Li S-Q, Cheng Y, et al. Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia. Cancer Cell Int. 2023;23(1):61.
Ji S, Chen F, Stein P, Wang J, Zhou Z, Wang L, Zhao Q, Lin Z, Liu B, Xu K, et al. OBOX regulates murine zygotic genome activation and early development. Nature. 2023.
Zhou L, Wu D, Zhou Y, Wang D, Fu H, Huang Q, Qin G, Chen J, Lv J, Lai S, et al. Publisher Correction: Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1. Nat Immunol. 2023.
Lv J, Liu X, Zhou Y, Cheng F, Chen H, Li S, Wang D, Zhou L, Wang Z, Zhou N, et al. YAP Inactivation by Soft Mechanotransduction Relieves MAFG for Tumor Cell Dedifferentiation. Research (Wash D C). 2023;6:0215.

Pages